| J9271 | Injection, pembrolizumab, 1 mg | 15,200 | $40 | $653.6K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 830 | $150 | $120.8K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 6,000 | $20 | $102K |
| J0897 | Injection, denosumab, 1 mg | 3,480 | $20 | $66.1K |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 1,890 | $30 | $64.3K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 27,160 | $1 | $54.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 520 | $100 | $50.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 330 | $110 | $37.1K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 210 | $100 | $20.8K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 290 | $60 | $17.7K |